Compare, Analyse Sun Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUN PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SUN PHARMA     Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SUN PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    SUN PHARMA
Mar-20
ADCOCK INGRAM
Jun-14
SUN PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs484383-   
Low Rs315276-   
Sales per share (Unadj.) Rs136.9113.9-  
Earnings per share (Unadj.) Rs17.5-28.7-  
Cash flow per share (Unadj.) Rs26.0-23.8-  
Dividends per share (Unadj.) Rs4.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs188.789.4-  
Shares outstanding (eoy) m2,399.26168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.92.9 100.9%   
Avg P/E ratio x22.9-11.5 -199.5%  
P/CF ratio (eoy) x15.4-13.9 -110.9%  
Price / Book Value ratio x2.13.7 57.5%  
Dividend payout %22.90-   
Avg Mkt Cap Rs m958,86455,608 1,724.3%   
No. of employees `00017.84.3 413.7%   
Total wages/salary Rs m63,6243,490 1,823.0%   
Avg. sales/employee Rs Th18,490.64,476.9 413.0%   
Avg. wages/employee Rs Th3,582.6813.0 440.7%   
Avg. net profit/employee Rs Th2,357.6-1,128.1 -209.0%   
INCOME DATA
Net Sales Rs m328,37519,219 1,708.6%  
Other income Rs m6,360135 4,725.4%   
Total revenues Rs m334,73519,354 1,729.6%   
Gross profit Rs m69,898-3,331 -2,098.7%  
Depreciation Rs m20,528829 2,474.8%   
Interest Rs m3,027521 581.5%   
Profit before tax Rs m52,702-4,546 -1,159.3%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-2,6060-   
Tax Rs m8,228284 2,896.5%   
Profit after tax Rs m41,868-4,843 -864.5%  
Gross profit margin %21.3-17.3 -122.8%  
Effective tax rate %15.6-6.2 -249.9%   
Net profit margin %12.8-25.2 -50.6%  
BALANCE SHEET DATA
Current assets Rs m316,54214,076 2,248.7%   
Current liabilities Rs m157,0647,920 1,983.1%   
Net working cap to sales %48.632.0 151.6%  
Current ratio x2.01.8 113.4%  
Inventory Days Days88111 78.9%  
Debtors Days Days105124 84.5%  
Net fixed assets Rs m243,1028,205 2,962.8%   
Share capital Rs m2,39989 2,688.8%   
"Free" reserves Rs m450,2450-   
Net worth Rs m452,64515,085 3,000.6%   
Long term debt Rs m20,2895,301 382.7%   
Total assets Rs m682,52528,497 2,395.1%  
Interest coverage x18.4-7.7 -238.1%   
Debt to equity ratio x00.4 12.8%  
Sales to assets ratio x0.50.7 71.3%   
Return on assets %6.6-15.2 -43.4%  
Return on equity %9.2-32.1 -28.8%  
Return on capital %11.2-19.8 -56.7%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m46,2550-   
CASH FLOW
From Operations Rs m65,5481,640 3,995.6%  
From Investments Rs m-25,888-504 5,139.5%  
From Financial Activity Rs m-57,1514,811 -1,187.9%  
Net Cashflow Rs m-13,8575,948 -233.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.28 Rs / ZAR

Compare SUN PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare SUN PHARMA With: SANOFI INDIA  DISHMAN PHARMA  ALEMBIC  FULFORD INDIA  PIRAMAL ENTERPRISES  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views On News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games? (The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave (Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

A Stock with 700% Return Potential Comes with Additional Payoffs (Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

Why Did the Market Crash on Monday? (Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits (Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More
-->

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

SUN PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK SUN PHARMA

  • Track your investment in SUN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON SUN PHARMA

SUN PHARMA 8-QTR ANALYSIS

COMPARE SUN PHARMA WITH

FEATURED VIDEOS

Market Crash: Picture Abhi Baaki Hai?

It's a Great Time to Buy Gold

The Dilemma of Investing in Bharti Airtel

Nifty: Bear Trap?

More Featured Videos

MARKET STATS